Are you sure?

Richter Q2 profit rises on subsidies

Gedeon Richter Rt, Hungary's biggest drugmaker, said second-quarter profit unexpectedly rose as because of the Russian government's new drug subsidies, prompting the company to raise its full-year sales forecast, daily Népszava reported. Non-consolidated net income at Budapest-based Richter rose to ft 10.8 billion forint, or ft 579 a share, from ft 10 billion, or 538 forint a share, in the year - earlier period, the company said.